Literature DB >> 27038970

The Link Between Infantile Colic and Migraine.

William Qubty1, Amy A Gelfand2.   

Abstract

Infantile colic is a self-limiting disorder of excessive infant crying or fussiness that peaks at 6 weeks of age and typically improves by 3 months of age. The etiology of infantile colic has yet to be definitively elucidated, but there is increasing research to support its relationship to migraine. The aims of this review are to present recent research investigating the connection between infantile colic and migraine. The importance of identifying this connection is useful in reducing invasive and potentially harmful investigations and to identify age appropriate pharmacologic interventions that would be safe in this population.

Entities:  

Keywords:  Baby migraine; Infantile colic; Migraine; Pediatric migraine

Mesh:

Substances:

Year:  2016        PMID: 27038970     DOI: 10.1007/s11916-016-0558-8

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  34 in total

1.  Evaluation of the efficacy of dicyclomine hydrochloride ('Merbentyl') syrup in the treatment of infant colic.

Authors:  F Grunseit
Journal:  Curr Med Res Opin       Date:  1977       Impact factor: 2.580

Review 2.  Nutritional supplements and other complementary medicines for infantile colic: a systematic review.

Authors:  Rachel Perry; Katherine Hunt; Edzard Ernst
Journal:  Pediatrics       Date:  2011-03-28       Impact factor: 7.124

Review 3.  Manipulative therapies for infantile colic.

Authors:  Dawn Dobson; Peter L B J Lucassen; Joyce J Miller; Arine M Vlieger; Philip Prescott; George Lewith
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

4.  Before the headache: infant colic as an early life expression of migraine.

Authors:  Amy A Gelfand; Katherine C Thomas; Peter J Goadsby
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

Review 5.  Dietary management of infantile colic: a systematic review.

Authors:  Marina Iacovou; Robin A Ralston; Jane Muir; Karen Z Walker; Helen Truby
Journal:  Matern Child Health J       Date:  2012-08

6.  Infants with "Colic"-mothers' perspectives on the crying problem.

Authors:  U Pauli-Pott; K Becker; T Mertesacker; D Beckmann
Journal:  J Psychosom Res       Date:  2000-02       Impact factor: 3.006

7.  Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.

Authors:  Susan R Orenstein; Eric Hassall; Wanda Furmaga-Jablonska; Stuart Atkinson; Marsha Raanan
Journal:  J Pediatr       Date:  2008-12-03       Impact factor: 4.406

8.  Infantile colic associated with childhood migraine: A prospective cohort study.

Authors:  Matti Sillanpää; Maiju Saarinen
Journal:  Cephalalgia       Date:  2015-03-09       Impact factor: 6.292

9.  Association between childhood migraine and history of infantile colic.

Authors:  Silvia Romanello; Daniele Spiri; Elena Marcuzzi; Anna Zanin; Priscilla Boizeau; Simon Riviere; Audrey Vizeneux; Raffaella Moretti; Ricardo Carbajal; Jean-Christophe Mercier; Chantal Wood; Gian Vincenzo Zuccotti; Giovanni Crichiutti; Corinne Alberti; Luigi Titomanlio
Journal:  JAMA       Date:  2013-04-17       Impact factor: 56.272

10.  Efficacy and tolerability of fixed-dose combination of dexketoprofen and dicyclomine injection in acute renal colic.

Authors:  A Porwal; A D Mahajan; D S Oswal; S S Erram; D N Sheth; S Balamurugan; V Kamat; R P Enadle; A Badadare; S K Bhatnagar; R S Walvekar; S Dhorepatil; R C Naik; I Basu; S N Kshirsagar; J V Keny; S Sengupta
Journal:  Pain Res Treat       Date:  2012-04-23
View more
  2 in total

Review 1.  Infantile colic.

Authors:  Valerie Sung
Journal:  Aust Prescr       Date:  2018-08-01

2.  Developing a core outcome set for infant colic for primary, secondary and tertiary care settings: a prospective study.

Authors:  Nina F Steutel; Marc A Benninga; Miranda W Langendam; Judith J Korterink; Flavia Indrio; Hania Szajewska; Merit M Tabbers
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.